We represented Verdi Oncology, Inc. in its acquisition of NexGen Oncology. With the acquisition of NexGen, Verdi has launched Verdi Cancer and Research Center of Texas. Terms of the transaction were not disclosed.
The center, led by Dr. Jivesh Sharma and Dr. Amy Cripps, will provide high quality medical oncology care and early phase clinical trials to patients in the greater Dallas-Fort Worth market. The new partnership marks Verdi’s entry into its fourth market since the company’s inception in 2018, following expansions into Indiana, Michigan and Tennessee.
Verdi Oncology, Inc., headquartered in Nashville, TN, is an oncology practice and clinical research management company focused on partnering with high-quality oncology physicians and practices.